Premier Alternatives

Slate Bio

Charlottesville, VA · Founded 2020 · Privately Held (backing)

Developer of a therapeutic platform intended to offer immunotherapeutics to resist autoimmune and inflammatory diseases. Slate Bio is based in Charlottesville, VA and was founded in 2020. It was valued at $11.3 million at its seed round in May 2023, the last priced event on record. It has raised $6 million across 2 recorded rounds; the latest was a $2.8 million seed round in Dec 2022.

PMV mark · valuation
$11.3M
Oct 2026
Priced at
its seed round
May 2023
Total raised
$6.0M
Last round
Seed Round
Dec 2022

Slate Bio key facts

as of Oct 2026
  • Developer of a therapeutic platform intended to offer immunotherapeutics to resist autoimmune and inflammatory diseases.
  • Slate Bio is valued at approximately $11.3M as of Oct 2026, set at its seed round, May 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $6.0M across 2 recorded rounds; the latest was Seed Round ($2.8M) in Dec 2022.
  • Notable investors include Virginia Innovation Partnership Corporation, Virginia Venture Partners, CAV Angels, University of Virginia, Epidarex Capital — 8 tracked in total.
  • Slate Bio has filed 3 Form Ds with the SEC since 2021, most recently May 2023 ($2.8M sold to 9 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$11.3M

Valued at $11.3M at its seed round, May 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Slate Bio with a free account
  • ·Watch Slate Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Slate Bio funding rounds

2 rounds
Dec 2022Seed Round$2.8MSEC filing▮
Dec 2020Seed Round$2.0MSEC filing▮
Full funding history →

Slate Bio valuation

Slate Bio was valued at $11.3 million at its seed round in May 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Slate Bio raised?

Slate Bio has raised $6 million in total; 2 of its rounds are on record. The largest on record was a $2.8 million seed round in Dec 2022.

Slate Bio has filed 3 Form Ds with the SEC since 2021, most recently in May 2023 ($2.8 million sold to 9 investors).

Slate Bio investors

8 investors are on record for Slate Bio, including Virginia Innovation Partnership Corporation, Virginia Venture Partners, CAV Angels and University of Virginia. The seed round in Dec 2022 drew 9 investors.

About Slate Bio

Developer of a therapeutic platform intended to offer immunotherapeutics to resist autoimmune and inflammatory diseases. The company creates therapies that restore the body's natural immunological response in various diseases using bifunctional cytokines, enabling patients a second independent synergistic pathway that has tissue selectivity and improved pharmacodynamics, at lower doses and without side effects.

Sector
Healthcare
HQ
Charlottesville, VA, United States
Founded
2020
Employees
5
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.